N4 Pharma (0GO) Income Statement

0 Followers

N4 Pharma Income Statement

Last quarter (Q2 2026), N4 Pharma's total revenue was £3.64K, an increase of 86.48% from the same quarter last year. In Q2, N4 Pharma's net income was £-754.93K. See N4 Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	£ 7.26K	£ 7.28K	£ 1.95K	£ 0.00	£ 0.00
Gross Profit	£ 7.26K	£ 7.28K	£ 1.95K	£ 0.00	£ 0.00
Operating Expenses	£ 1.11M	£ 1.17M	£ 1.43M	£ 1.19M	£ 1.84M
Depreciation and Amortization	£ 0.00	£ 0.00	£ 89.17K	£ 228.49K	£ 236.56K
EBITDA	£ -1.10M	£ -1.22M	£ -1.33M	£ -1.19M	£ -1.84M
Operating Income	£ -1.10M	£ -1.22M	£ -1.43M	£ -1.19M	£ -1.84M
Other Income/Expenses	£ 61.13K	£ -61.21K	£ 0.00	£ 0.00	£ 677.00
Pretax Income	£ -1.10M	£ -1.22M	£ -1.43M	£ -1.19M	£ -1.84M
Net Income	£ -1.21M	£ -1.06M	£ -1.27M	£ -1.03M	£ -1.54M
Per Share Metrics
Basic EPS	£ >-0.01	£ >-0.01	£ >-0.01	£ >-0.01	£ -0.01
Diluted EPS	£ >-0.01	£ >-0.01	£ >-0.01	£ >-0.01	£ -0.01
Weighted Average Shares Outstanding	724.40M	340.39M	242.89M	186.42M	181.08M
Weighted Average Shares Outstanding (Diluted)	724.40M	340.88M	242.89M	186.42M	181.08M

Currency in GBP

N4 Pharma (0GO) Income Statement

N4 Pharma Income Statement

N4 Pharma Earnings and Revenue History